Abstract

Severe Motor Polyneuropathy Secondary to The Use of Vincristine in A Patient with Acute Lymphoblastic Leukaemia In the Period April 2013

Describe the severe motor polyneuropathy secondary to the use of Vincristine in a patient with acute lymphoblastic leukemia in the period of April 2013.

Specific objectives:

1. Determine the sociodemographic characteristics of patients in study.

2. Identify the factors that favoured the onset of motor polyneuropathy secondary to the use of vincristine in the patient study.

3. To determine the clinical manifestations of the patient.

4. To describe the electrophysiological changes secondary motor polyneuropathy the use of vincristine in the patient study.


Author(s):

Cristhian Berrios



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+